Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Convertible Preferred Stock [Member]	Series A Convertible Preferred Stock [Member]	Series B Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Loss [Member]	Accumulated Deficit [Member]
Temporary equity, Beginning balance at Dec. 31, 2020		$ 21,624
Temporary equity, Beginning balance (in shares) at Dec. 31, 2020		6,838,829
Beginning balance at Dec. 31, 2020	$ (14,638)				$ 1	$ 100		$ (14,739)
Beginning balance (in shares) at Dec. 31, 2020					1,046,599
Issuance of convertible preferred stock, net of issuance costs			$ 55,722	$ 124,825
Issuance of convertible preferred stock, net of issuance costs (in shares)			5,894,740	8,038,073
Conversion of convertible preferred stock to common stock in connection with initial public offering, converted	(202,171)	$ (202,171)
Conversion of convertible preferred stock to common stock in connection with initial public offering, converted (in shares)		(20,771,642)
Conversion of convertible preferred stock to common stock in connection with initial public offering, issued	202,171				$ 27	202,144
Conversion of convertible preferred stock to common stock in connection with initial public offering, issued (in shares)					26,608,460
Initial public offering, net of issuance costs	204,167				$ 13	204,154
Initial public offering, net of issuance costs (in shares)					13,110,000
Exercise of common stock options	20					20
Exercise of common stock options (in shares)					113,418
Shares issued under employee stock purchase plan	164					164
Shares issued under employee stock purchase plan (in shares)					11,452
Vesting of restricted shares	475					475
Vesting of restricted shares (in shares)					353,208
Stock-based compensation	6,910					6,910
Unrealized loss on available-for-sale securities, net	(270)						$ (270)
Net loss	(32,672)							(32,672)
Ending balance at Dec. 31, 2021	366,327				$ 41	413,967	(270)	(47,411)
Ending balance (in shares) at Dec. 31, 2021					41,243,137
Conversion of convertible preferred stock to common stock in connection with initial public offering, converted	0
Exercise of common stock options	$ 1					1
Exercise of common stock options (in shares)	7,405				7,405
Shares issued under employee stock purchase plan	$ 499					499
Shares issued under employee stock purchase plan (in shares)					54,299
Vesting of restricted shares	1,034				$ 1	1,033
Vesting of restricted shares (in shares)					311,419
Stock-based compensation	17,203					17,203
Unrealized loss on available-for-sale securities, net	(1,265)						(1,265)
Net loss	(63,059)							(63,059)
Ending balance at Dec. 31, 2022	$ 320,740				$ 42	$ 432,703	$ (1,535)	$ (110,470)
Ending balance (in shares) at Dec. 31, 2022					41,616,260